{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:22:04Z","timestamp":1767907324641,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.thromres.2014.07.020","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T21:00:53Z","timestamp":1406149253000},"page":"884-888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients"],"prefix":"10.1016","volume":"134","author":[{"given":"Rossella","family":"Marcucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serafina","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Chiostri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Paniccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betti","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Cau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Franco","family":"Gensini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.07.020_bb0005","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Working Group on High On Treatment Platelet Reactivity. Consensus and future directions on the definition of high on treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.07.020_bb0010","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2011.1332","article-title":"High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI","volume":"306","author":"Parodi","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.thromres.2014.07.020_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","article-title":"Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up","volume":"119","author":"Marcucci","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.07.020_bb0020","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.thromres.2014.07.020_bb0025","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jacc.2008.05.032","article-title":"Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents","volume":"52","author":"Gori","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.thromres.2014.07.020_bb0030","first-page":"279","article-title":"High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting","volume":"104","author":"Marcucci","year":"2010","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.thromres.2014.07.020_bb0035","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/hrt.2010.220491","article-title":"High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention","volume":"97","author":"Breet","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2014.07.020_bb0040","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/CIRCULATIONAHA.109.876763","article-title":"C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation","volume":"120","author":"Park","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.thromres.2014.07.020_bb0045","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/clc.20403","article-title":"Biomarkers on admission for the prediction of cardiovascular events after primary stenting in patients with ST-elevation myocardial infarction","volume":"31","author":"Jeong","year":"2008","journal-title":"Clin Cardiol"},{"issue":"11","key":"10.1016\/j.thromres.2014.07.020_bb0050","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1253\/circj.70.1379","article-title":"Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome","volume":"70","author":"Kim","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.thromres.2014.07.020_bb0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.04.001","article-title":"The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients","volume":"202","author":"Gori","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2014.07.020_bb0060","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.jacc.2011.08.057","article-title":"A point-of-care platelet function assay and c-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation","volume":"58","author":"Park","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.07.020_bb0065","first-page":"287","article-title":"Comparison of methods for monitoring residual platelet reactivity after clopidogrel by poin-of-care tests on whole blood in high-risk patients","volume":"104","author":"Paniccia","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.07.020_bb0070","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/hrt.2006.099762","article-title":"Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation","volume":"93","author":"Park","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2014.07.020_bb0075","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.amjcard.2005.11.060","article-title":"C-reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents","volume":"97","author":"Gaspardone","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2014.07.020_bb0080","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcin.2012.09.013","article-title":"High-dose atorvastatin on the pharmacodynamics effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: the ACHIDO study","volume":"6","author":"Leoncini","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.thromres.2014.07.020_bb0085","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"GRAVITAS Investigators. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2014.07.020_bb0090","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"ARCTIC Investigators. Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2014.07.020_bb0095","first-page":"39","article-title":"Simvastatin reduces platelet thromboxane formation and restores normal platelet reactivity against prostacyclin in type II hypercholesterolemia","volume":"2","author":"Schr\u00f6r","year":"1989","journal-title":"Eicosanoids"},{"key":"10.1016\/j.thromres.2014.07.020_bb0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.ATV.15.2.247","article-title":"Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hyperlipoproteinemia","volume":"15","author":"Notarbartolo","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2014.07.020_bb0105","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.108.768283","article-title":"Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid. Determinants and effect on cardiovascular risk","volume":"118","author":"Eikelboom","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.07.020_bb0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000093226","article-title":"Low-density lipoprotein-lowering medication and platelet function","volume":"35","author":"Ferroni","year":"2006","journal-title":"Pathophysiol Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.07.020_bb0115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and risks of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.thromres.2014.07.020_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCINTERVENTIONS.109.879312","article-title":"Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial","volume":"2","author":"Dosh","year":"2009","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814003958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814003958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:37:14Z","timestamp":1758735434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814003958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0049384814003958"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.07.020","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}